CVE-2005-4398
** DISPUTED ** NOTE: the vendor has disputed this issue. Cross-site scripting (XSS)...
NOTE: the vendor has disputed this issue. Cross-site scripting (XSS) vulnerability in lemoon 2.0 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified search parameters, possibly the q parameter. NOTE: the vendor has disputed this issue, saying "Sites are built on top of ASP.NET and you use lemoon core objects to easily manage and render content. The XSS vuln. you are referring to exists in one of our public sites built on lemoon i.e. a custom made site (as all sites are). The problem exists in a UserControl that handles form input and is in no way related to the lemoon core product.
Exploit likelihood
What each source reports
NVD Score used
4.3
NOTE: the vendor has disputed this issue. Cross-site scripting (XSS) vulnerability in lemoon 2.0 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified search parameters, possibly the q parameter. NOTE: the vendor has disputed this issue, saying "Sites are built on top of ASP.NET and you use lemoon core objects to easily manage and render content. The XSS vuln. you are referring to exists in one of our public sites built on lemoon i.e. a custom made site (as all sites are). The problem exists in a UserControl that handles form input and is in no way related to the lemoon core product.
- Record
CVE-2005-4398- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
NOTE: the vendor has disputed this issue. Cross-site scripting (XSS) vulnerability in lemoon 2.0 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified search parameters, possibly the q parameter. NOTE: the vendor has disputed this issue, saying "Sites are built on top of ASP.NET and you use lemoon core objects to easily manage and render content. The XSS vuln. you are referring to exists in one of our public sites built on lemoon i.e. a custom made site (as all sites are). The problem exists in a UserControl that handles form input and is in no way related to the lemoon core product.
- Record
CVE-2005-4398- Updated
- 2026-11-02
EUVDEUVD-2005-4393 No score
NOTE: the vendor has disputed this issue. Cross-site scripting (XSS) vulnerability in lemoon 2.0 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified search parameters, possibly the q parameter. NOTE: the vendor has disputed this issue, saying "Sites are built on top of ASP.NET and you use lemoon core objects to easily manage and render content. The XSS vuln. you are referring to exists in one of our public sites built on lemoon i.e. a custom made site (as all sites are). The problem exists in a UserControl that handles form input and is in no way related to the lemoon core product.
- Record
EUVD-2005-4393- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-4rgc-4rc7-mg92 No score
** DISPUTED ** NOTE: the vendor has disputed this issue. Cross-site scripting (XSS)...
** DISPUTED ** NOTE: the vendor has disputed this issue. Cross-site scripting (XSS) vulnerability in lemoon 2.0 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified search parameters, possibly the q parameter. NOTE: the vendor has disputed this issue, saying "Sites are built on top of ASP.NET and you use lemoon core objects to easily manage and render content. The XSS vuln. you are referring to exists in one of our public sites built on lemoon i.e. a custom made site (as all sites are). The problem exists in a UserControl that handles form input and is in no way related to the lemoon core product."
- Record
GHSA-4rgc-4rc7-mg92- Updated
- 2026-11-02
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2005-4398 is a medium vulnerability (CVSS 4.3), published December 20, 2005. Its validity is disputed. EPSS puts the chance of exploitation in the next 30 days at 1.21%, the 68th percentile.